Goldman Sachs Group Inc Adma Biologics, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,611,677 shares of ADMA stock, worth $55.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,611,677
Previous 1,033,103
152.8%
Holding current value
$55.8 Million
Previous $11.6 Million
352.01%
% of portfolio
0.01%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$398 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$387 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$278 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$270 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$184 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...